Dr. Li has over 15 years of experience through global translational research, clinical development, and medical affairs. Dr. Li used to be a doctor and PhD supervisor in Tier 3 Hospital in Shanghai, China, leading the grant of “National Natural Science Foundation”. Then she worked in Top 10 Global Pharms AstraZeneca, Novartis, Abbott and Chinese Pharma Hengrui, played critical roles in physician, Medical Manager, TA head and National Medical Director in broad therapeutic areas of Oncology, Rheumatology & Immunology, Gastroenterology& Hepatology, Hematology, Nephrology, Cardiovascular disease, Diabetes, etc. She successfully built medical and clinical operation team, managed over 100 clinical trials, owns a stellar track-record in shaping innovative portfolio development and products launching strategy. Dr. Li received her Ph.D. degree of Medicine from Erasmus Medical Center in the Netherlands (Top1 Medical Center in Europe 2009), where she discovered the role of IL-6/IL-17 signaling and JAK/STAT/SOCS pathway in autoimmune disease and GI oncology. She received her M.D. title from Wuhan University Zhongnan Hospital, and her EMBA degree from Shanghai Jiao-Tong University in China. Dr. Li has 10 book publications, 57 scientific manuscript & poster publications, and 10+ Chinese guidelines contribution. She served editor role in 10+ scientific journals. In China professional societies and advisory committees, she worked as Editor-in-Chief on public books of “Guideline on Post marketing Studie” and “RWD and RWE” where earned great honor and impact.